To generalize our observations to prostate cancer cells, we developed ADI-resistant clones (PC3-ADIR) and ASS1-overexpressing clones (PC3-ASS1) in prostate cancer PC3 cell line. The gene discussed is ASS1; the disease is prostate carcinoma.